Screener
Tango Therapeutics TNGX Operating Lease Liabilities
Operating Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Tango Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityNoncurrent.
The source filing: Tango Therapeutics’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-221656
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Accrued expenses and other current liabilities | 9,068 | 17,759 |
| Operating lease liabilities | 2,832 | 2,738 |
| Total current liabilities | 14,330 | 21,679 |
| Operating lease liabilities, net of current portion | 29,956 | 30,832 |
| Total liabilities | 44,286 | 52,511 |
| Commitments and contingencies (Note 7) | ||
| Preferred stock, $0.001 par value; 10,000,000 shares authorized; no shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively | — | — |
| Stockholders' equity: |
Item 1. Financial Statements.
FAQ
- What is Tango Therapeutics's operating lease liabilities?
- Tango Therapeutics (TNGX) reported operating lease liabilities of $29.96M in Q1 2026.
- How has Tango Therapeutics's operating lease liabilities changed year-over-year?
- Tango Therapeutics's operating lease liabilities decreased by 12.2% year-over-year, from $34.12M to $29.96M.
- What is the long-term trend for Tango Therapeutics's operating lease liabilities?
- Over 4 years (2020 to 2025), Tango Therapeutics's operating lease liabilities has grown at a 45.3% compound annual growth rate (CAGR), from $6.93M to $30.83M.
- What does operating lease liabilities mean?
- Long-term portion of operating lease obligations extending beyond one year, representing committed future rent payments.
Ask your AI about Tango Therapeutics's operating lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude